422
Views
17
CrossRef citations to date
0
Altmetric
Uterine Fibroids

The levonorgestrel-releasing intrauterine system: its effect on the number of hysterectomies performed in perimenopausal women with uterine fibroids

, , , , &
Pages 492-495 | Received 15 Oct 2012, Accepted 20 Jan 2013, Published online: 06 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Giovanni Grandi, Pierluigi Di Vinci, Alice Sgandurra, Lia Feliciello, Francesca Monari & Fabio Facchinetti. (2022) Contraception During Perimenopause: Practical Guidance. International Journal of Women's Health 14, pages 913-929.
Read now
Mohamed Ali, Sara A.R.Ayman Al Hendy. (2021) Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Expert Review of Clinical Pharmacology 14:4, pages 427-437.
Read now
Anita L Nelson. (2013) Progestin-only treatments for acute and chronic heavy menstrual bleeding. Expert Review of Endocrinology & Metabolism 8:4, pages 307-309.
Read now

Articles from other publishers (13)

Jarbas Magalhaes, Edson Santos Ferreira-Filho, Jose Maria Soares-Junior & Edmund Chada Baracat. (2022) Uterine volume, menstrual patterns, and contraceptive outcomes in users of the levonorgestrel-releasing intrauterine system: A cohort study with a five-year follow-up. European Journal of Obstetrics & Gynecology and Reproductive Biology 276, pages 56-62.
Crossref
Dillon Savard & Ashley Brown. (2022) Is the levonorgestrel intrauterine system effective in decreasing menorrhagia caused by uterine leiomyoma (fibroids)?. Evidence-Based Practice 25:3, pages 36-37.
Crossref
Jong-Kil JooJung-Ho ShinJung Ryeol LeeMee-Ran Kim. (2021) Levonorgestrel-Releasing Intrauterine System Use in Perimenopausal Women. Journal of Menopausal Medicine 27:2, pages 49.
Crossref
Amanda L Patterson, Jitu W George, Anindita Chatterjee, Tyler J Carpenter, Emily Wolfrum, David W Chesla & Jose M Teixeira. (2020) Putative human myometrial and fibroid stem-like cells have mesenchymal stem cell and endometrial stromal cell properties. Human Reproduction 35:1, pages 44-57.
Crossref
Amanda Black & Edith Guilbert. (2019) Consensus canadien sur la contraception (partie 3 de 4): chapitre 7 - Contraception intra-utérine. Journal of Obstetrics and Gynaecology Canada 41, pages S1-S23.
Crossref
Hoda ElKafas, Mohamed Ali & Ayman Al-Hendy. 2018. Encyclopedia of Reproduction. Encyclopedia of Reproduction 101 105 .
Mohamed Ali & Ayman Al-Hendy. (2017) Selective progesterone receptor modulators for fertility preservation in women with symptomatic uterine fibroids†. Biology of Reproduction 97:3, pages 337-352.
Crossref
Suk Bong Koh. (2017) Current Medical Therapy for Uterine Leiomyomas. Kosin Medical Journal 32:1, pages 17-24.
Crossref
Valentina Shaw, Alain C. Vandal, Christin Coomarasamy & Alec J. Ekeroma. (2016) The effectiveness of the levonorgestrel intrauterine system in obese women with heavy menstrual bleeding. Australian and New Zealand Journal of Obstetrics and Gynaecology 56:6, pages 619-623.
Crossref
Banafsheh N. Kashani, Gabriele Centini, Sara S. Morelli, Gerson Weiss & Felice Petraglia. (2016) Role of Medical Management for Uterine Leiomyomas. Best Practice & Research Clinical Obstetrics & Gynaecology 34, pages 85-103.
Crossref
Amanda Black, Edith Guilbert, Dustin Costescu, Sheila Dunn, William Fisher, Sari Kives, Melissa Mirosh, Wendy Norman, Helen Pymar, Robert Reid, Geneviève Roy, Hannah Varto, Ashley Waddington, Marie-Soleil Wagner & Anne Marie Whelan. (2016) Canadian Contraception Consensus (Part 3 of 4): Chapter 7 – Intrauterine Contraception. Journal of Obstetrics and Gynaecology Canada 38:2, pages 182-222.
Crossref
Dirk WildemeerschAmaury Andrade & Norman Goldstuck. (2016) Femilis® 60 Levonorgestrel-Releasing Intrauterine System–-A Review of 10 Years of Clinical Experience. Clinical Medicine Insights: Reproductive Health 10, pages CMRH.S40087.
Crossref
Nathalie Chabbert-Buffet, Nathalie Esber & Philippe Bouchard. (2014) Fibroid growth and medical options for treatment. Fertility and Sterility 102:3, pages 630-639.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.